Original Article

Green Synthesis, Characterization, and Antileishmanial Activity of the Silver Nanoparticles Alone and Along with Meglumine Antimoniate against Leishmania major Infection

Abstract

Background: The most commonly available drugs for leishmaniasis are pentavalent antimony compounds; whereas the recent studies showed various complications and limitations of these drugs. We aimed to green synthesized silver nanoparticles (AgNPs) and study the promising antileishmanial and synergic effects of green synthesized silver nanoparticles alone and combined with glucantime.
Methods: The precipitation technique was used to drop silver ions via an extract of Astragalus spinosus to AgNPs at Department of Biological Sciences, Faculty of Science and Humanities, Shaqra University, Saudi Arabia in 2022. Then, its anti-amastigotes, caspase-3-like activity, triggering the nitric oxide (NO) as well as its cytotoxicity effects on macrophage cells as well as effects on leishmaniasis in BALB/c mice infected by L. major were measured.
Results: The size of the AgNPs were ranging from 30-40 nm. The IC50 value for AgNPs, AgNPs+ meglumine antimoniate (MA), and MA was 59.3, 18.6, and 51.2 μg/mL, respectively. The determined FIC value for AgNPs and MA was found to be 0.31 and 0.36, respectively; demonstrating the synergistic potency of AgNPs when combined with MA. The diameter of CL lesions treated with various doses of AgNPs and AgNPs+MA notably (p<0.001) decreased. AgNPs, particularly at the concentrations of ½ IC50 and IC50, considerably triggered the caspase-3 activation. The calculated CC50 of AgNPs and MA was 612.5 and 789.8 μg/mL, respectively. Green synthesized AgNPs, especially in combination with MA had synergic antileishmanial effects and displayed a promising drug candidate for treating L. major CL.
Conclusion: We found satisfactory findings in the parasite reduction in both in vitro and animal models. Still, more studies are expected to explain the precise action mechanisms of AgNPs and their efficacy in humans.

1. Torres-Guerrero E, Quintanilla-Cedillo MR, Ruiz-Esmenjaud J, Arenas R. Leishmaniasis: a review. F1000Res. 2017; 6:750.
2. Alemayehu B, Alemayehu M. Leishmaniasis: a review on parasite, vector and reservoir host. Health Sci J. 2017;11(4):519.
3. Monzote L. Current treatment of leishmaniasis: a review. Open Antimicrob Agent J. 2009;1(1):9-19.
4. Santos DO, Coutinho CE, Madeira MF, et al. Leishmaniasis treatment—a challenge that remains: a review. Parasitol Res. 2008;103(1):1-10.
5. Kulkarni N, Muddapur U. Biosynthesis of metal nanoparticles: a review. J Nanotechnol. 2014;2014.
6. Jadoun S, Arif R, Jangid NK, Meena RK. Green synthesis of nanoparticles using plant extracts: A review. Environ Chem Lett. 2021;19(1):355-74.
7. Nafari A, Cheraghipour K, Sepahvand M, Shahrokhi G, Gabal E, Mahmoudvand H. Nanoparticles: New agents toward treatment of leishmaniasis. Parasite Epidemiol Control. 2020; 10:e00156.
8. Albalawi AE, Alanazi AD, Baharvand P, Sepahvand M, Mahmoudvand H. High potency of organic and inorganic nanoparticles to treat cystic echinococcosis: an evidence-based review. Nanomaterials (Basel). 2020;10(12):2538.
9. Albalawi AE, Khalaf AK, Alyousif MS, et al. Fe3O4@ piroctone olamine magnetic nanoparticles: Synthesize and therapeutic potential in cutaneous leishmaniasis. Biomed Pharmacother. 2021; 139:111566.
10. Mohebali M, Rezayat MM, Gilani K, et al. Nanosilver in the treatment of localized cutaneous leishmaniasis caused by Leishmania major (MRHO/IR/75/ER): an in vitro and in vivo study. Daru J Pharm Sci. 2015;17(4):285-9.
11. Rios JL, Waterman PG. A review of the pharmacology and toxicology of Astragalus. Phytother Res. 1997;11(6):411-8.
12. Albalawi AE, Althobaiti NA, Alhasani RH, Alnomasy SF. Anti-tumor effects and cellular mechanisms of Pistacia atlantica methanolic extract against Ehrlich solid tumor in mice. Asian Pacific J Trop Biomed. 2022;12(2):69.
13. Masoumi-Ardakani Y, Mahmoudvand H, Mirzaei A, et al. The effect of Elettaria cardamomum extract on anxiety-like behavior in a rat model of post-traumatic stress disorder. Biomed Pharmacother. 2017; 87:489-95.
14. Awad MA, Al Olayan EM, Siddiqui MI, Merghani NM, Alsaif SS, Aloufi AS. Antileishmanial effect of silver nanoparticles: Green synthesis, characterization, in vivo and in vitro assessment. Biomed Pharmacother. 2021;137:111294.
15. Mahmoudvand H, Sepahvand P, Jahanbakhsh S, Azadpour M. Evaluation of the antileishmanial and cytotoxic effects of various extracts of garlic (Allium sativum) on Leishmania tropica. J Parasit Dis. 2016;40(2):423-6.
16. Albalawi AE, Abdel-Shafy S, Khudair Khalaf A, et al. Therapeutic potential of green synthesized copper nanoparticles alone or combined with meglumine antimoniate (glucantime®) in cutaneous leishmaniasis. Nanomaterials (Basel). 2021;11(4):891.
17. Yadegari JG, Khalaf AK, Ezzatkhah F, Shakibaie M, Mohammadi HR, Mahmoudvand H. Antileishmanial, cellular mechanisms, and cytotoxic effects of green synthesized zinc nanoparticles alone and in combined with glucantime against Leishmania major infection. Biomed Pharmacother. 2023; 164:114984.
18. Ezzatkhah F, Khalaf AK, Mahmoudvand H. Copper nanoparticles: Biosynthesis, characterization, and protoscolicidal effects alone and combined with albendazole against hydatid cyst protoscoleces. Biomed Pharmacother. 2021; 136:111257.
19. Mahmoudvand H, Dezaki ES, Ezatpour B, Sharifi I, Kheirandish F, Rashidipour M. In vitro and in vivo antileishmanial activities of Pistacia vera essential oil. Planta Med. 2016;82(4):279-84.
20. Albalawi AE, Alanazi AD, Sharifi I, Ezzatkhah F. A Systematic Review of Curcumin and its Derivatives as Valuable Sources of Antileishmanial Agents. Acta Parasitol. 2021; 66(3):797-811.
21. AlMohammed HI, Khudair Khalaf A, E Albalawi A, et al. Chitosan-based nanomaterials as valuable sources of anti-leishmanial agents: a systematic review. Nanomaterials (Basel). 2021;11(3):689.
22. Koushik O, Rao Y, Kumar P, Karthikeyan R. Nano drug delivery systems to overcome cancer drug resistance-a review. J Nanomed Nanotechnol. 2016;7(378):2-11.
23. Lemesre JL, Sereno D, Daulouede S, Veyret B, Brajon N, Vincendeau P. Leishmania spp.: Nitric Oxide-Mediated Metabolic Inhibition of Promastigote and Axenically Grown Amastigote Forms. Exp Parasitol. 1997;86(1):58-68.
24. Zangger H, Mottram JC, Fasel N. Cell death in Leishmania induced by stress and differentiation: programmed cell death or necrosis? Cell Death Differ. 2002;9(10):1126-39.
25. Jabir MS, Saleh YM, Sulaiman GM, et al. Green synthesis of silver nanoparticles using Annona muricata extract as an inducer of apoptosis in cancer cells and inhibitor for NLRP3 inflammasome via enhanced autophagy. Nanomaterials (Basel). 2021;11(2):384.
26. Nedaie S, Akbari H, Yaghoubi H. Cytotoxicity Effects of Green Synthesized Silver Nanoparticles by Using the Extract of Tuber Spp. on Breast Cancer (MCF-7) Cells. J Babol Uni Med Sci. 2019;21(1):242-8.
27. Sukirtha R, Priyanka KM, Antony JJ, et al. Cytotoxic effect of Green synthesized silver nanoparticles using Melia azedarach against in vitro HeLa cell lines and lymphoma mice model. Process Biochem. 2012;47(2):273-9.
Files
IssueVol 18 No 4 (2023) QRcode
SectionOriginal Article(s)
DOI https://doi.org/10.18502/ijpa.v18i4.14262
Keywords
Leishmania major Nanomedicine Silver nanoparticles Cytotoxicity Mechanism
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Majeed Q, Shater AF, Alanazi A. Green Synthesis, Characterization, and Antileishmanial Activity of the Silver Nanoparticles Alone and Along with Meglumine Antimoniate against Leishmania major Infection. Iran J Parasitol. 2023;18(4):535-545.